US Stock MarketDetailed Quotes
ABMC AMERICAN BIO MEDICA CORP
- 0.000100
- 0.0000000.00%
15min DelayClose May 28 16:00 ET
4.81KMarket Cap0.01P/E (TTM)
0.000100High0.000100Low636Volume0.000100Open0.000100Pre Close0.06Turnover0.00%Turnover RatioLossP/E (Static)48.10MShares0.01680052wk High-0.01P/B4.80KFloat Cap0.00000152wk Low--Dividend TTM47.95MShs Float0.100000Historical High--Div YieldTTM0.00%Amplitude0.000001Historical Low0.000000Avg Price1Lot Size
AMERICAN BIO MEDICA CORP Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -53.28%164K | -58.84%913K | -67.19%167K | -65.96%209K | -65.03%185K | -37.99%351K | -46.52%2.22M | -34.49%509K | -30.46%614K | -69.91%529K |
| Operating revenue | -53.28%164K | -58.84%913K | -67.19%167K | -65.96%209K | -65.03%185K | -37.99%351K | -46.52%2.22M | -34.49%509K | -30.46%614K | -69.91%529K |
| Cost of revenue | -72.14%90K | -33.77%1.11M | -20.47%307K | -49.18%218K | -34.35%258K | -29.93%323K | -42.59%1.67M | -29.43%386K | -33.80%429K | -66.58%393K |
| Gross profit | 164.29%74K | -118.80%-103K | -140.65%-50K | -104.86%-9K | -153.68%-73K | -73.33%28K | -55.74%548K | -46.52%123K | -21.28%185K | -76.63%136K |
| Operating expense | -20.33%286K | -34.05%1.14M | -26.96%252K | -34.96%253K | -27.89%274K | -41.53%359K | -7.10%1.73M | -18.44%345K | -4.42%389K | -32.86%380K |
| Selling and administrative expenses | -23.44%258K | -35.81%1.05M | -28.79%230K | -37.23%231K | -28.69%256K | -43.27%337K | -7.18%1.64M | -21.22%323K | -3.92%368K | -34.37%359K |
| -Selling and marketing expense | -52.38%20K | -54.93%137K | -60.56%28K | -67.09%26K | -43.06%41K | -49.40%42K | -38.34%304K | -16.47%71K | -11.24%79K | -68.70%72K |
| -General and administrative expense | -19.32%238K | -31.46%917K | -19.84%202K | -29.07%205K | -25.09%215K | -42.27%295K | 4.86%1.34M | -22.46%252K | -1.70%289K | -9.46%287K |
| Research and development costs | 27.27%28K | 0.00%85K | 0.00%22K | 4.76%22K | -14.29%18K | 10.00%22K | -5.56%85K | 69.23%22K | -12.50%21K | 10.53%21K |
| Operating profit | 35.95%-212K | -5.34%-1.24M | -36.04%-302K | -28.43%-262K | -42.21%-347K | 34.97%-331K | -89.86%-1.18M | -15.03%-222K | -18.60%-204K | -1,625.00%-244K |
| Net non-operating interest income expense | 56.25%-21K | 1.55%-191K | 22.45%-38K | -8.16%-53K | -6.12%-52K | -2.13%-48K | -10.86%-194K | -16.67%-49K | -16.67%-49K | -32.43%-49K |
| Non-operating interest income | ---- | --3K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Non-operating interest expense | -56.25%21K | 0.00%194K | -16.33%41K | 8.16%53K | 6.12%52K | 2.13%48K | 10.86%194K | 16.67%49K | 16.67%49K | 32.43%49K |
| Other net income (expense) | 2.11M | -97.26%25K | 142.59%23K | -99.89%1K | -98.00%1K | 45,500.00%912K | -54K | 916K | 50K | |
| Special income (charges) | --3.04M | --0 | --0 | --0 | ---- | --0 | --235K | ---100K | --335K | ---- |
| -Less:Impairment of capital assets | ---- | --0 | ---- | ---- | ---- | ---- | --100K | ---- | ---- | ---- |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---335K | --0 | ---335K | ---- |
| -Gain on sale of property,plant,equipment | --3.04M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Other non- operating income (expenses) | ---921K | -96.31%25K | -50.00%23K | -99.83%1K | -98.00%1K | ---- | 33,750.00%677K | --46K | --581K | --50K |
| Income before tax | 596.31%1.88M | -205.42%-1.41M | 2.46%-317K | -147.36%-314K | -63.79%-398K | 31.83%-379K | 41.94%-461K | -39.48%-325K | 409.81%663K | -1,057.14%-243K |
| Income tax | 0 | 0.00%2K | 0 | 0 | 0.00%2K | 0 | 0.00%2K | 0 | 0 | 2K |
| Net income | 596.31%1.88M | -204.54%-1.41M | 2.46%-317K | -147.36%-314K | -63.27%-400K | 31.83%-379K | 41.83%-463K | -39.48%-325K | 406.94%663K | -1,066.67%-245K |
| Net income continuous Operations | 596.31%1.88M | -204.54%-1.41M | 2.46%-317K | -147.36%-314K | -63.27%-400K | 31.83%-379K | 41.83%-463K | -39.48%-325K | 406.94%663K | -1,066.67%-245K |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 596.31%1.88M | -204.54%-1.41M | 2.46%-317K | -147.36%-314K | -63.27%-400K | 31.83%-379K | 41.83%-463K | -39.48%-325K | 406.94%663K | -1,066.67%-245K |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 596.31%1.88M | -204.54%-1.41M | 2.46%-317K | -147.36%-314K | -63.27%-400K | 31.83%-379K | 41.83%-463K | -39.48%-325K | 406.94%663K | -1,066.67%-245K |
| Basic earnings per share | 500.00%0.04 | -200.00%-0.03 | -54.15%-0.01 | -150.00%-0.01 | 0.00%-0.01 | 0.00%-0.01 | 50.00%-0.01 | 35.13%-0.0065 | 300.00%0.02 | -1,609.40%-0.01 |
| Diluted earnings per share | 500.00%0.04 | -200.00%-0.03 | -54.15%-0.01 | -150.00%-0.01 | 0.00%-0.01 | 0.00%-0.01 | 50.00%-0.01 | 35.13%-0.0065 | 300.00%0.02 | -1,609.40%-0.01 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg